A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 25,397 shares of BAX stock, worth $856,132. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,397
Previous 9,272 173.91%
Holding current value
$856,132
Previous $310,000 210.97%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.85 - $40.26 $529,706 - $649,192
16,125 Added 173.91%
25,397 $964,000
Q2 2024

Jul 23, 2024

BUY
$32.87 - $43.55 $304,770 - $403,795
9,272 New
9,272 $310,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.